ICL Group Ltd.
No enriched coverage for $ICL in the last 7 days.
No SEC Form 4 filings for $ICL in the last 30 days.
See all $ICL insider activity →Simply Wall St says ICL Group (NYSE:ICL) reported Q2 2026 sales of $2,135 million and net income of $137 million, and its board approved a new end-market operating model. The stock rose 9.90% over 30 days to $5.55 but is down 13.55% over 90 days. The article cites P/E 23.5x and a DCF value of $8.65.
ICL Group Ltd reported Q2 2026 sales of US$2,135 million and net income of US$137 million, higher than a year earlier, and approved an organizational restructuring effective Jan. 1, 2027. The plan reorganizes operations around Agriculture, Food, and Industrial end markets, elevating specialty crop nutrition and advanced food and beverage solutions.
ICL Fincorp launched a public issue of Secured Redeemable Non-Convertible Debentures (NCDs) starting 10 Aug 2026 and open until 21 Aug 2026, offering effective yields up to 12.25%. CRISIL rating is BBB-/STABLE. Face value is ₹1,000 per NCD with tenures of 13 to 72 months and interest rates from 10.00% to 12.25%. Proceeds will fund growth initiatives.
Recent ICL coverage spans earnings, financial news and corporate actions.
The article frames ICL’s earnings and operating-model change as a near-term momentum rebound, but highlights longer-term risk from cyclicality and slower benefits.
The earnings beat and the planned end-market reorganization are near-term sentiment positives, but the restructuring’s financial impact is deferred into 2027.
The NCD issue is a funding event that can affect near-term credit perception and balance-sheet leverage expectations for ICL Fincorp.
Guidance reaffirmation is offset by a clear second-half cost risk from sulfur and freight, plus a margin headwind from higher-cost inventory.
Results and reiterated 2026 EBITDA guidance support a constructive near-term earnings outlook, with upside risk if pricing/demand remain firm.
alphai scores every news story that mentions ICL with an AI model for sentiment and relevance, and aggregates insider trades from ICL Group Ltd.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Simply Wall St says ICL Group (NYSE:ICL) reported Q2 2026 sales of $2,135 million and net income of $137 million, and its board approved a new end-market operating model. The stock rose 9.90% over 30 days to $5.55 but is down 13.55% over 90 days. The article cites P/E 23.5x and a DCF value of $8.65.
6 min readICL Group Ltd reported Q2 2026 sales of US$2,135 million and net income of US$137 million, higher than a year earlier, and approved an organizational restructuring effective Jan. 1, 2027. The plan reorganizes operations around Agriculture, Food, and Industrial end markets, elevating specialty crop nutrition and advanced food and beverage solutions.
4 min readICL Fincorp launched a public issue of Secured Redeemable Non-Convertible Debentures (NCDs) starting 10 Aug 2026 and open until 21 Aug 2026, offering effective yields up to 12.25%. CRISIL rating is BBB-/STABLE. Face value is ₹1,000 per NCD with tenures of 13 to 72 months and interest rates from 10.00% to 12.25%. Proceeds will fund growth initiatives.
2 min readICL Group (NYSE:ICL) reported Q2 potash sales of $468 million (+22%) and EBITDA of $154 million (+34%). Potash price averaged $376/ton CIF (+13% YoY). Phosphate Solutions sales rose to $722 million (+13%). Management kept 2026 consolidated EBITDA guidance at $1.5B to $1.7B and reiterated sulfur and Brazil risks.
6 min readICL reported Q2 2026 sales of $2.1 billion, up 17% from $1.8 billion a year earlier, citing stronger pricing and demand. Operating income rose to $266 million from $181 million, and net income to $137 million from $93 million. Adjusted EBITDA was $448 million. ICL reiterated FY2026 adjusted EBITDA guidance of $1.5 billion to $1.7 billion and potash volumes of 4.5 to 4.7 million metric tons.
2 min readICL Group reported Q2 2026 sales of $2.1 billion, up 17%, and adjusted EBITDA of $448 million, up 28%, citing higher potash, bromine and phosphate prices. Adjusted net income rose 35% to $149 million, and adjusted EPS rose 33% to $0.12. Free cash flow was $94 million. Full-year 2026 EBITDA guidance was reiterated at $1.5 billion to $1.7 billion.
6 min readICL Group (NYSE: ICL) reported Q2 2026 results for the quarter ended June 30, 2026. Consolidated sales rose to $2.1 billion (+17% Y/Y). Operating income increased to $266 million from $181 million, and net income attributable to shareholders rose to $137 million from $93 million. ICL reiterated FY2026 adjusted EBITDA guidance of $1.5B to $1.7B and expects potash volumes of 4.5 to 4.7 million metric tons.
6 min readThe article says ICL Group (formerly Israel Chemicals) canceled a planned $574 million St. Louis EV battery materials plant after the Trump administration withdrew a pledged $197 million. It also reports that St. Louis approved tax incentives for an ICL facility, citing Defense Department contracts linking the plant to white phosphorus supply. Bayer says it sells only limited third-party elemental phosphorus, not for military use.
7 min readIsrael’s Tel Aviv Stock Exchange was flat after a late rally. TA-35 rose 0.07% to 4,058.08 and TA-125 fell 0.07% to 4,004.34. Oil & Gas gained 2% led by Delek Group (DELKG) up 4.44% after a Delek Initiatives spin-off. Turnover was NIS 3.60B equities and NIS 3.52B bonds. Shekel strengthened vs dollar and euro.
3 min readSOMO, a Dutch watchdog, says the Netherlands received €44.9 billion of Israeli capital in 2024 and invested €27.3 billion into Israel, much routed through Dutch holding companies with limited local activity. It cites Rafael’s “letterbox” holding via Ercas BV and mentions Teva, ICL, Elbit, Check Point and Palo Alto Networks. SOMO urges Dutch sanctions and possible end of the 1973 tax treaty.
6 min read
